Application of a Decision Support Tool for Anticoagulation in Patients with Non-valvular Atrial Fibrillation
Open Access
- 29 March 2008
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 23 (4) , 411-417
Abstract
Atrial fibrillation affects more than two million Americans and results in a fivefold increased rate of embolic strokes. The efficacy of adjusted dose warfarin is well documented, yet many patients are not receiving treatment consistent with guidelines. The use of a patient-specific computerized decision support tool may aid in closing the knowledge gap regarding the best treatment for a patient. This retrospective, observational cohort analysis of 6,123 Ohio Medicaid patients used a patient-specific computerized decision support tool that automated the complex risk–benefit analysis for anticoagulation. Adverse outcomes included acute stroke, major gastrointestinal bleeding, and intracranial hemorrhage. Cox proportional hazards models were developed to compare the group of patients who received warfarin treatment with those who did not receive warfarin treatment, stratified by the decision support tool’s recommendation. Our decision support tool recommended warfarin for 3,008 patients (49%); however, only 9.9% received warfarin. In patients for whom anticoagulation was recommended by the decision support tool, there was a trend towards a decreased hazard for stroke with actual warfarin treatment (hazard ratio 0.90) without significant increase in gastrointestinal hemorrhage (0.87). In contrast, in patients for whom the tool recommended no anticoagulation, receipt of warfarin was associated with statistically significant increased hazard of gastrointestinal bleeding (1.54, p = 0.03). We have shown that our atrial fibrillation decision support tool is a useful predictor of those at risk of major bleeding for whom anticoagulation may not necessarily be beneficial. It may aid in weighing the benefits versus risks of anticoagulation treatment.Keywords
This publication has 55 references indexed in Scilit:
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive SummaryJACC, 2006
- Age and the Risk of Warfarin‐Associated Hemorrhage: The Anticoagulation and Risk Factors In Atrial Fibrillation StudyJournal of the American Geriatrics Society, 2006
- Patterns and Predictors of Warfarin Use in Patients With New-Onset Atrial Fibrillation from the FRACTAL RegistryThe American Journal of Cardiology, 2006
- Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (The Framingham Heart Study)The American Journal of Cardiology, 2004
- Use of Regression Modeling to Simulate Patient-Specific Decision Analysis for Patients with Nonvalvular Atrial FibrillationMedical Decision Making, 2003
- Can Patients Be Anticoagulated After Intracerebral Hemorrhage?Stroke, 2003
- Warfarin for Stroke Prevention Still Underused in Atrial FibrillationStroke, 2000
- Adverse Outcomes and Predictors of Underuse of Antithrombotic Therapy in Medicare Beneficiaries With Chronic Atrial FibrillationStroke, 2000
- Agreement between Drug Treatment Data and a Discharge Diagnosis of Diabetes Mellitus in the ElderlyAmerican Journal of Epidemiology, 1999
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991